Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3c2e77f8dfda692ca527454d23ecc03 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-064 |
filingDate |
2018-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_832f12adf3ae71b05f95820f0411ddb9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_becb3961d3d890dd3f5b1aacaa23d763 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21d6a324963d4ab2a5d646ba9e247ed0 |
publicationDate |
2018-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2018227129-A1 |
titleOfInvention |
Skin care formulations and skin cancer treatment |
abstract |
An example technique for treating a skin cancer condition includes administering a therapeutically effective amount of a p53-related protein kinase (PRPK) inhibitor to a patient having skin cancer or having a high risk of developing skin cancer. An example composition includes a therapeutically effective amount of a PRPK inhibitor for treating a skin cancer condition. An example composition includes a pharmaceutically effective amount of at least one anti-solar ultraviolet (anti-sUV) combination for preventing a skin cancer condition. The at least one anti-sUV combination is chosen from the combinations: avobenzone and octinoxate; octocrylene and zinc oxide; avobenzone, octocrylene, and titanium dioxide; or avobenzone, octocrylene, and zinc oxide. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10836789-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11110103-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10472387-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11571432-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11090314-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112110880-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11208432-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102141451-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10857163-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11124537-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10723759-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110240624-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112110880-B |
priorityDate |
2017-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |